Clinical trial
The ASPIRE Trial: AchilleS tendinoPathy Treated With cortIcosteRoid injEctions
NCT07650396 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The ASPIRE Trial: AchilleS tendinoPathy Treated With cortIcosteRoid injEctions
- Lead sponsor
- Erasmus Medical Center
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- June 3, 2026
- Completion date
- October 31, 2028
- Enrollment
- 276 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
achilles tendinopathy (at)